Discover 3,580 paid clinical trials in Irvine, California. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Clinical trials in Irvine address a diverse range of conditions, from mental health disorders and neurological diseases to skin conditions and cardiovascular issues. As one of California’s thriving research hubs, the city provides participants with a chance to explore cutting-edge therapies and receive specialized care, all while contributing to the advancement of medical science in their region.
Filter
2
Filter results
Results: 3,580
The EndRAD Trial: Eliminating Total Body Irradiation (TBI) for NGS-MRD Negative Children, Adolescents, and Young Adults With B-ALL
for
B-cell Acute Lymphoblastic Leukemia
Location: Duarte CA, Los Angeles CA, Phoenix AZ, Oakland CA,
Location: Orange CA, Bakersfield CA, Chandler AZ, Queen Creek AZ,
Sponsor: UroGen Pharma Ltd.
Sex: All
Age: 18+
Code: NCT06774131
Phase3, Recruiting
A Clinical Investigation to Follow the Progress of Exuding Chronic Wounds Using Mepilex® Up as the Primary Dressing.
for
Wounds, Wound of Skin, Wound Leg, Wound; Foot,
Location: Los Angeles CA, Castro Valley CA, Pittsburgh PA,
Sponsor: Molnlycke Health Care AB
Sex: All
Age: 18+
Code: NCT05588583
Recruiting
Lung Cancer Screening of Family Members of Patients With Mutation-Driven Lung Cancer
for
Lung Cancer, Driver Mutation
Location: Orange CA
Sponsor: University of California, Irvine
Sex: All
Age: 18 - 70+
Code: NCT07062172
Recruiting
A Single-Arm Phase II Study of Neoadjuvant Intensified Androgen Deprivation (Leuprolide and Abiraterone Acetate) in Combination With AKT Inhibition (Capivasertib) for High-Risk Localized Prostate Cancer With PTEN Loss
for
High-Risk Prostate Cancer
Location: West Los Angeles CA, Portland OR, Seattle WA,
Sponsor: VA Office of Research and Development
Sex: Male
Age: 18+
Code: NCT05593497
Phase2, Recruiting
A Study of BMS-986482 Alone or as Combination Therapy in Participants With Advanced Solid Tumors
for
Advanced Solid Tumors
Location: Irvine CA, Los Angeles CA, Seattle WA, Charlotte NC,
Sponsor: Bristol-Myers Squibb
Sex: All
Age: 18+
Code: NCT06697197
Phase1, Phase2, Recruiting
A Long-term Study Evaluating Hepatotoxicity Associated With TURALIO™ (Pexidartinib) Treatment
for
Hepatotoxicity, Tenosynovial Giant Cell Tumor
Location: Santa Monica CA, Columbus OH, Boston MA
Sponsor: Daiichi Sankyo
Sex: All
Age: 18+
Code: NCT04635111
Recruiting
Multi-antigen CMV-Modified Vaccinia Ankara Vaccine in Treating Pediatric Patients With Positive Cytomegalovirus Undergoing Donor Stem Cell Transplant
for
Cytomegaloviral Infection,
Location: Duarte CA
Sponsor: City of Hope Medical Center
Sex: All
Age: 1 - 21
Code: NCT03354728
Phase1, Phase2, Recruiting
A Study to Investigate Progression-Free Survival With Sonrotoclax Plus Obinutuzumab Or Sonrotoclax Plus Rituximab Compared With Venetoclax Plus Rituximab Treatment In Patients With Relapsed and/or Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CELESTIAL-RRCLL)
for
Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma
Location: Orange CA, Laguna Hills CA, San Diego CA, Palo Alto CA,
Sponsor: BeOne Medicines
Sex: All
Age: 18+
Code: NCT06943872
Phase3, Recruiting
Understanding Prefrontal and Medial Temporal Neuronal Responses to Algorithmic Cognitive Variables in Epilepsy Patients
for
Epilepsy
Location: Los Angeles CA, Houston TX
Sponsor: Baylor College of Medicine
Sex: All
Age: 10 - 64
Code: NCT05283811
Recruiting
Study of the Use of Laser Light to Treat Osteoarthritis of the Hand.
for
Osteoarthritis
Location: Long Beach CA, Phoenix AZ, Bloomington MN
Sponsor: TriTech Manufacturing
Sex: All
Age: 18+
Code: NCT00254111
Recruiting
AMBER-HFpEF: Assessment of CK-4021586 in a Multi-Center, Blinded Evaluation of Safety and Tolerability Results in HFpEF
for
Symptomatic Heart Failure With Preserved Ejection Fraction (HFpEF),
Location: Pasadena CA, Vista CA, Imperial CA, Santa Maria CA,
Sponsor: Cytokinetics
Sex: All
Age: 40 - 70+
Code: NCT06793371
Phase2, Recruiting
Response Adapted Neoadjuvant Therapy in Gastroesophageal Cancers (RANT-GC Trial)